Paul Tudor Jones’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Hold
15,700
﹤0.01% 3387
2026
Q1
$85.6K Sell
15,700
-112,000
-88% -$628K ﹤0.01% 3463
2025
Q4
$894K Buy
+127,700
New +$1,000K ﹤0.01% 2349
2025
Q1
Sell
-11,600
Closed -$105K 3665
2024
Q4
$105K Sell
11,600
-17,300
-60% -$167K ﹤0.01% 2905
2024
Q3
$265K Sell
28,900
-35,900
-55% -$297K ﹤0.01% 2385
2024
Q2
$634K Buy
+64,800
New +$790K ﹤0.01% 1698
2024
Q1
Sell
-149,900
Closed -$3.23M 2774
2023
Q4
$3.23M Buy
+149,900
New +$2.77M 0.03% 857
2022
Q4
Sell
-8,700
Closed -$220K 2839
2022
Q3
$220K Sell
8,700
-2,800
-24% -$98.2K ﹤0.01% 2001
2022
Q2
$383K Buy
11,500
+7,600
+195% +$323K 0.01% 1422
2022
Q1
$281K Buy
3,900
+1,200
+44% +$86.5K 0.01% 1586
2021
Q4
$246K Sell
2,700
-7,000
-72% -$837K ﹤0.01% 1995
2021
Q3
$1.23M Buy
+9,700
New +$1.41M 0.02% 1018

Other funds holding TDOC

Paul Tudor Jones's TDOC Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Teladoc Health (TDOC) in Q2 2026: 387,807 shares worth $3.29M. The stake represents ﹤0.01% of the portfolio and ranks #1583 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in TDOC as recently as Q3 2024.

Paul Tudor Jones first reported a position in TDOC in Q2 2018 and has held it in 15 quarters since. The position peaked at $5.33M in Q2 2023. 345 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Paul Tudor Jones held 387,807 shares of Teladoc Health worth $3.29M as of Q2 2026.
  • Teladoc Health was a new Paul Tudor Jones position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1583 holding.
  • Paul Tudor Jones first reported a position in Teladoc Health in Q2 2018 and has held it in 15 quarters since.
  • Paul Tudor Jones's Teladoc Health position peaked at $5.33M in Q2 2023.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.